These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2837625)

  • 21. Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective.
    Hull RD; Raskob GE; Rosenbloom D; Pineo GF; Lerner RG; Gafni A; Trowbridge AA; Elliott CG; Green D; Feinglass J
    Arch Intern Med; 1997 Feb; 157(3):289-94. PubMed ID: 9040295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [LMWH and UFH in direct comparison. Consent: CERTIFY].
    MMW Fortschr Med; 2007 May; 149(20):53. PubMed ID: 18051967
    [No Abstract]   [Full Text] [Related]  

  • 23. Low molecular weight heparins: deep vein thrombosis prophylaxis in elective hip surgery and thrombotic stroke.
    Turpie AG
    Acta Chir Scand Suppl; 1988; 543():85-6. PubMed ID: 2847462
    [No Abstract]   [Full Text] [Related]  

  • 24. Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.
    Hull RD; Pineo GF; Stein P
    Int Angiol; 1998 Dec; 17(4):213-24. PubMed ID: 10204652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevention of thromboembolism with heparin and dihydroergotamine (DHE) in internal medicine--comparison of various administration forms of dihydroergotamine].
    Schott G; Kreibich U; Sommer S; Möckel G; Beitz R; Rothe G
    Z Arztl Fortbild (Jena); 1988; 82(11):509-11. PubMed ID: 3051706
    [No Abstract]   [Full Text] [Related]  

  • 26. [Preventive treatment in internal medicine by low-molecular-weight heparin (nadroparine calcium)].
    Martyin T; Jakucs J; Iványi J; Kis E; Varga I; Mellár E
    Orv Hetil; 1998 Dec; 139(51):3065-9. PubMed ID: 9914726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Internist patients are strongly thrombosis endangered. CERTIFY study has arrived].
    MMW Fortschr Med; 2007 May; 149(20):52-3. PubMed ID: 18051966
    [No Abstract]   [Full Text] [Related]  

  • 28. [The thromboprophylactic effect of low molecular weight heparin (Fragmin) in hip fracture surgery. A placebo controlled trial].
    Jørgensen PS; Knudsen JB; Broeng L; Josephsen IL; Bjerregaard P; Hagen KK; Jørgensen PK; Tørholm C
    Ugeskr Laeger; 1993 Mar; 155(10):706-8. PubMed ID: 8384388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Stroke with leg paralysis -- cardioversion in atrial fibrillation: prevention of thromboembolism in risk patients].
    MMW Fortschr Med; 2006 Jun; 148(23):58-9. PubMed ID: 16826742
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevention of venous thromboembolism among hospitalized medical patients.
    Goldhaber SZ; Turpie AG
    Circulation; 2005 Jan; 111(1):e1-3. PubMed ID: 15630031
    [No Abstract]   [Full Text] [Related]  

  • 31. [Is anticoagulation with heparins in phenprocoumon treated patients safe during operations?].
    Hoppe UC
    Dtsch Med Wochenschr; 2002 Nov; 127(44):2345. PubMed ID: 12410442
    [No Abstract]   [Full Text] [Related]  

  • 32. Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism: a meta-analysis.
    Couturaud F; Julian JA; Kearon C
    Thromb Haemost; 2001 Oct; 86(4):980-4. PubMed ID: 11686355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low molecular weight heparin (KABI 2165) as thromboprophylaxis in elective visceral surgery. A randomized, double-blind study versus unfractionated heparin.
    Koller M; Schoch U; Buchmann P; Largiadèr F; von Felten A; Frick PG
    Thromb Haemost; 1986 Dec; 56(3):243-6. PubMed ID: 3551180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extended thromboprophylaxis with low molecular weight heparin reduces symptomatic venous thromboembolism following lower limb arthroplasty--a meta-analysis.
    Cohen AT; Bailey CS; Alikhan R; Cooper DJ
    Thromb Haemost; 2001 May; 85(5):940-1. PubMed ID: 11372694
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prevention of thromboembolism with low-molecular-weight heparin in ambulatory surgery and unoperated surgical and orthopedic patients].
    Harenberg J; Piazolo L; Misselwitz F
    Zentralbl Chir; 1998; 123(11):1284-7. PubMed ID: 9880848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-molecular-weight heparin versus oral anticoagulant therapy for the long-term treatment of symptomatic venous thromboembolism: Is there any difference in cancer-related mortality?
    Ferretti G; Bria E; Giannarelli D; Carlini P; Felici A; Mandala M; Papaldo P; Nistico C; Fabi A; Cuppone F; Gelibter A; Terzoli E; Cognetti F
    J Clin Oncol; 2005 Oct; 23(28):7248-50; author reply 7250. PubMed ID: 16192623
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevention of fatal pulmonary embolism and mortality in surgical patients: a randomized double-blind comparison of LMWH with unfractionated heparin.
    Haas S; Wolf H; Kakkar AK; Fareed J; Encke A
    Thromb Haemost; 2005 Oct; 94(4):814-9. PubMed ID: 16270636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Venous thromboembolism in cancer patients: expanding horizons.
    Bergqvist D
    Semin Thromb Hemost; 2002 Aug; 28 Suppl 3():19-23. PubMed ID: 12232819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Venous thromboembolism in the medically ill patient: a call to action.
    Bergmann JF; Kher A
    Int J Clin Pract; 2005 May; 59(5):555-61. PubMed ID: 15857352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ACCP Consensus Conference on Antithrombotic Therapy. Indicate specific low molecular weight heparin product and dosage.
    Lobo BL; Greene WL
    Chest; 1996 Sep; 110(3):866. PubMed ID: 8797452
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.